Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjunctive therapy in anaemia management.

Walter H Hörl1

  • 1Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria. walter.hoerl@nephro.imed3.akh-wien.ac.at

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|July 2, 2002
PubMed
Summary

Iron supplementation is crucial for patients receiving erythropoiesis-stimulating agents. Intravenous iron may be preferred over oral iron for end-stage renal disease patients due to absorption issues and potential adverse effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Iron Dosing Strategies in Patients Undergoing Long-Term Hemodialysis: A Randomized Controlled Trial.

Clinical journal of the American Society of Nephrology : CJASN·2021
Same author

Pathophysiology and Treatment of Hyperhomocysteinemia in End-Stage Renal Disease Patients.

Hemodialysis international. International Symposium on Home Hemodialysis·2017
Same author

Nonsteroidal Anti-Inflammatory Drugs and the Kidney.

Pharmaceuticals (Basel, Switzerland)·2016
Same author

Use of Calcium Channel Blockers is Associated with Mortality in Patients with Chronic Kidney Disease.

Kidney & blood pressure research·2015
Same author

Increased chemokine excretion in patients suffering from chronic kidney disease.

Translational research : the journal of laboratory and clinical medicine·2014
Same author

Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.

Clinical biochemistry·2014

Area of Science:

  • Nephrology
  • Hematology
  • Pharmacology

Background:

  • Iron supplementation is vital for patients undergoing treatment with recombinant human erythropoietin (rHuEPO) or darbepoetin alfa.
  • Oral iron is often insufficient for patients with end-stage renal disease (ESRD) due to limited absorption, necessitating alternative strategies.
  • Intravenous (IV) iron preparations like dextran, gluconate, and sucrose are available, but dextran carries risks of serious adverse reactions.

Purpose of the Study:

  • To review the efficacy and safety of iron supplementation in renal anemia.
  • To discuss the role of oxidative stress and potential interventions like vitamin E and melatonin.
  • To explore the impact of carnitine metabolism and L-carnitine supplementation on renal anemia in ESRD patients.

Main Methods:

Related Experiment Videos

  • Review of current literature on iron supplementation for renal anemia.
  • Analysis of the effectiveness of different iron formulations (oral vs. IV).
  • Examination of the role of oxidative stress and potential therapeutic agents (vitamin E, melatonin, L-carnitine).

Main Results:

  • IV iron preparations are often necessary for ESRD patients due to oral iron's inadequacy.
  • Oxidative stress, exacerbated by rHuEPO therapy, can reduce red blood cell lifespan and rHuEPO efficacy; vitamin E and melatonin may mitigate this.
  • L-carnitine supplementation has shown promise in improving hematocrit and reducing rHuEPO requirements in hemodialysis patients.

Conclusions:

  • Careful monitoring of iron parameters is essential to prevent over-treatment.
  • Alternative IV iron preparations to dextran may be preferred due to safety concerns.
  • While L-carnitine shows potential benefits for renal anemia in ESRD, further recommendations are pending.